Korea and Singapore Regulators Sign Trade MOU For Drugs, Devices
This article was originally published in PharmAsia News
SEOUL - Korea's FDA and Singapore's Health Sciences Authority have signed a memorandum of understanding as part of their efforts to ensure the safety, quality and efficacy of health products traded between the two countries
You may also be interested in...
SEOUL - U.S. FDA is encouraging regulatory counterparts in Asia Pacific Economic Cooperation forum countries to adopt a multi-layered approach to combat counterfeit drugs
More Talks Needed With China and Japan For Cooperation In Sharing Clinical Data - Korea FDA Official
SEOUL - Although drug regulatory officials from South Korea, Japan and China met in Beijing for two days from Dec. 17 in their second tri-party meeting, they failed to report "noticeable progress" in their pursuit of an integrated clinical trial data-sharing program and mutual acceptance of their rules and guidelines, according to Korea FDA
SEOUL - South Korean President Lee Myung-bak named "17 new growth engines" at a science and technology council meeting at his office in Seoul Jan. 13. Expected to spearhead the country's economic growth for the next 10 years, of those 17 economic growth engines, the Korean government targeted biologics, medical devices and global health care among the national priorities